YLR462W Antibody

What is YLR462W and what is its significance in yeast research?

YLR462W refers to a specific open reading frame (ORF) in the Saccharomyces cerevisiae genome, corresponding to UniProt accession number O13556. This gene is part of the extensive catalog of yeast proteins studied in molecular biology and genetics research. The YLR462W antibody specifically recognizes and binds to the protein product of this gene, enabling researchers to track its expression, localization, and interactions within yeast cells. Unlike many well-characterized yeast genes, YLR462W remains under investigation regarding its complete functional profile, making antibodies against this protein valuable tools for expanding our understanding of yeast biology and potential homologous functions in other organisms .

What are the primary applications for YLR462W antibodies in yeast research?

YLR462W antibodies serve multiple experimental purposes in yeast research, particularly in studies investigating protein expression, localization, and functional characterization. The primary applications include Western blotting for protein expression analysis, immunoprecipitation (IP) for studying protein-protein interactions, immunocytochemistry (ICC) for cellular localization studies, and chromatin immunoprecipitation (ChIP) if the protein has DNA-binding properties. These antibodies are especially valuable in comparative studies between different yeast strains, such as when investigating functional genomics in standard laboratory strains like S288c versus other specialized strains like JAY291 or YJM789, which are also represented in antibody collections .

How do I select the appropriate YLR462W antibody format for my experimental needs?

When selecting a YLR462W antibody format, consider the specific requirements of your experimental approach. For Western blot and immunoprecipitation applications, polyclonal antibodies often provide higher sensitivity due to their recognition of multiple epitopes, though this may come with increased background. For precise localization studies, monoclonal antibodies typically offer higher specificity. Additionally, consider whether your experimental design requires conjugated antibodies (HRP, fluorophore, biotin) for direct detection versus unconjugated primary antibodies that will require a secondary detection system. The catalog format for YLR462W antibodies available from suppliers typically includes both 2ml and 0.1ml size options, which should be selected based on your anticipated experimental scale and frequency .

What information about YLR462W can be derived from studies in different yeast strains?

Comparative studies using YLR462W antibodies across different yeast strains can reveal important biological insights. The antibody catalog shows availability for detection in various strains including the standard laboratory strain (ATCC 204508/S288c), as well as specialized strains like JAY291 and YJM789 . When the same protein shows differential expression, localization, or interaction patterns across these strains, researchers can infer strain-specific regulation or functional adaptation. This approach is particularly valuable when investigating biological processes that vary between laboratory-adapted and wild yeast strains, or when studying the effects of different genetic backgrounds on protein function. For example, similar comparative approaches have been used successfully in studies of arsenic resistance genes (ARR1, ARR2, ARR3) in Saccharomyces cerevisiae, revealing how gene positioning and copy number affect expression and function .

What are the optimal conditions for Western blot analysis using YLR462W antibodies?

For optimal Western blot results with YLR462W antibodies, begin with proper sample preparation by using a yeast-specific lysis buffer containing protease inhibitors to prevent protein degradation. A recommended starting dilution ratio for YLR462W antibody is 1:1000 for Western blot applications, though this should be empirically optimized for your specific experimental conditions. Use 5% non-fat dry milk or 3% BSA in TBST for blocking to minimize background. For detection, a 1-2 hour primary antibody incubation at room temperature or overnight at 4°C typically yields optimal results. When troubleshooting, consider that yeast proteins often require more stringent extraction methods compared to mammalian samples due to their robust cell walls. Include appropriate positive controls from verified yeast strains known to express YLR462W and negative controls such as knockout strains if available .

How can I optimize immunoprecipitation protocols using YLR462W antibodies?

For successful immunoprecipitation with YLR462W antibodies, optimize cell lysis conditions specifically for yeast samples, typically using glass bead disruption in a lysis buffer containing 50mM Tris-HCl (pH 7.5), 150mM NaCl, 0.1% NP-40, and protease inhibitors. Pre-clear lysates with protein A/G beads to reduce non-specific binding. Use 2-5μg of YLR462W antibody per mg of total protein, and incubate overnight at 4°C with gentle rotation. When designing controls, include a no-antibody condition and ideally an isotype control antibody. After IP, wash beads 4-5 times with increasingly stringent wash buffers to reduce background while maintaining specific interactions. For challenging yeast proteins, consider crosslinking approaches or tandem affinity purification methods if traditional IP yields poor results. Finally, validate IP results with reciprocal co-immunoprecipitation or mass spectrometry to confirm specific protein-protein interactions .

What methods can I use to validate the specificity of YLR462W antibodies?

Rigorous validation of YLR462W antibody specificity is essential for reliable research outcomes. Begin with Western blot analysis comparing wild-type yeast strains with YLR462W knockout or depleted strains if available. The absence of signal in knockout samples strongly supports antibody specificity. Additionally, perform peptide competition assays by pre-incubating the antibody with the immunizing peptide before application to your samples; specific antibodies will show significantly reduced signal. For advanced validation, consider mass spectrometry analysis of immunoprecipitated material to confirm the presence of YLR462W and absence of cross-reactive proteins. When working with multiple yeast strains, test specificity across strain variations, as differences in protein sequence or post-translational modifications may affect antibody recognition. Finally, orthogonal detection methods such as RNA expression correlation with protein levels can provide additional confidence in antibody specificity .

How should I design controls for experiments using YLR462W antibodies?

Robust experimental design with appropriate controls is critical when working with YLR462W antibodies. Include positive controls using yeast strains known to express YLR462W, such as the ATCC 204508/S288c strain. For negative controls, use either YLR462W knockout strains or samples treated with YLR462W-targeting siRNA/shRNA to confirm signal specificity. Additionally, include technical controls such as secondary-antibody-only samples to assess non-specific binding of the detection system and isotype controls to identify background arising from the antibody class rather than antigen specificity. For quantitative experiments, prepare a standard curve using recombinant YLR462W protein if available. When comparing results across different experimental conditions, include loading controls appropriate for the specific application, such as total protein stains for Western blots or housekeeping gene products for immunocytochemistry .

How can YLR462W antibodies be used in studies of protein-protein interactions?

YLR462W antibodies can be powerful tools for investigating protein-protein interactions through several complementary approaches. The primary method is co-immunoprecipitation (co-IP), where YLR462W antibodies are used to capture the target protein along with its interaction partners from yeast lysates. For increased stringency, consider using crosslinking agents like formaldehyde or DSP before lysis to stabilize transient interactions. After IP, interacting proteins can be identified by Western blot if candidate interactors are suspected, or by mass spectrometry for unbiased discovery of the complete interactome. Additionally, proximity labeling approaches (BioID or APEX) can be combined with YLR462W antibodies for validation of interactions in their native cellular context. For visualization of interactions in intact cells, consider Förster resonance energy transfer (FRET) or bimolecular fluorescence complementation (BiFC) paired with immunofluorescence using YLR462W antibodies to confirm expression and localization .

What considerations should be made when using YLR462W antibodies across different yeast species or strains?

Cross-species and cross-strain applications of YLR462W antibodies require careful consideration of sequence conservation and epitope accessibility. When extending from S. cerevisiae strain ATCC 204508/S288c to other strains or related yeast species, perform sequence alignment of the YLR462W protein to assess homology, particularly in the epitope region targeted by the antibody. The catalog shows antibodies developed for specific strains including S288c, JAY291, and YJM789, suggesting potential variation in optimal antibody selection . For novel applications in unstudied strains, validate antibody performance through Western blot analysis comparing the reference strain with your strain of interest. If signals differ significantly, consider epitope mapping to identify the specific binding region, which may inform redesign of experimental approaches. In comparative studies like those performed for arsenic resistance genes across yeast strains, genetic variations can significantly impact protein expression and function, making strain-specific validation of antibody performance essential .

How do post-translational modifications affect YLR462W antibody recognition?

Post-translational modifications (PTMs) can profoundly impact antibody recognition of YLR462W protein. Phosphorylation, ubiquitination, SUMOylation, and glycosylation may either mask or create epitopes, altering antibody binding affinity. When investigating PTMs, consider using multiple antibodies targeting different regions of YLR462W to develop a complete picture of the protein's modification state. Phosphorylation-specific antibodies may be particularly valuable if YLR462W is known to be regulated by kinase activity. For complex studies of PTMs, combine immunoprecipitation using total YLR462W antibodies followed by Western blotting with modification-specific antibodies. Alternatively, immunoprecipitate with modification-specific antibodies and detect with total YLR462W antibodies. To determine if PTMs are affecting your results, consider treating samples with phosphatases, deubiquitinases, or deglycosylation enzymes before antibody application to establish the contribution of each modification to the observed signal .

What approaches can be used for quantitative analysis of YLR462W protein levels?

Quantitative analysis of YLR462W protein requires carefully optimized methodologies to ensure accurate and reproducible results. For Western blot-based quantification, establish a linear detection range using serial dilutions of your sample and measure band intensities within this range using densitometry software. Include recombinant YLR462W protein at known concentrations to generate a standard curve if absolute quantification is needed. For increased precision, consider quantitative dot blot arrays or automated Western platforms that offer greater reproducibility than traditional methods. Flow cytometry can be employed for single-cell quantification if working with fluorescently-tagged antibodies, providing insights into cell-to-cell variation in expression levels. For highest precision, consider targeted mass spectrometry approaches such as selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) with isotopically labeled reference peptides, which offer excellent specificity and quantitative accuracy, particularly when antibody-based methods show limitations .

How can I troubleshoot non-specific binding when using YLR462W antibodies?

Non-specific binding is a common challenge when working with yeast antibodies, including those targeting YLR462W. If experiencing high background or multiple unexpected bands, first optimize your blocking solution by testing alternatives such as 5% BSA instead of milk, or adding 0.1-0.3% Tween-20 to reduce hydrophobic interactions. Increase the number and stringency of washing steps, potentially adding higher salt concentrations (up to 500mM NaCl) to disrupt weak non-specific interactions. Consider pre-absorbing the antibody with yeast lysate from a YLR462W knockout strain to remove antibodies that bind non-specifically to other yeast proteins. If Western blots show multiple bands, perform peptide competition assays to identify which bands represent specific binding. For immunofluorescence applications with high background, include an additional blocking step with normal serum from the species in which the secondary antibody was raised. Finally, titrate both primary and secondary antibodies to find the optimal concentration that maximizes specific signal while minimizing background .

What are the best practices for antibody storage and handling to maintain YLR462W antibody activity?

Proper storage and handling of YLR462W antibodies is critical for maintaining their activity and specificity over time. Store antibodies at -20°C for long-term storage, divided into small aliquots (20-50μl) to avoid repeated freeze-thaw cycles, which can lead to antibody degradation and loss of function. When removing from storage, thaw antibodies on ice rather than at room temperature to preserve functionality. For working solutions, store at 4°C with preservatives like 0.02% sodium azide, but use within 1-2 weeks. Avoid vortexing antibodies as this can cause denaturation; instead, mix by gentle inversion or flicking. Before each use, centrifuge antibody vials briefly to collect liquid at the bottom and remove any precipitates. If storing diluted antibodies, use the buffer recommended by the manufacturer, typically PBS with 0.5% BSA and 0.02% sodium azide. Regularly validate antibody performance using positive controls to ensure activity has not diminished over time .

How can I determine the optimal dilution and incubation conditions for YLR462W antibodies?

Determining optimal conditions for YLR462W antibodies requires systematic optimization for each application. Begin with the manufacturer's recommended dilution range, typically starting at 1:1000 for Western blotting and 1:100 for immunofluorescence with the standard 2ml antibody preparation . Perform a dilution series (e.g., 1:500, 1:1000, 1:2000) to identify the concentration that provides the best signal-to-noise ratio. For incubation times, compare 1-hour room temperature versus overnight 4°C incubations to determine optimal kinetics for your specific experiment. Temperature can significantly impact antibody binding kinetics; higher temperatures increase reaction rates but may also increase non-specific binding. For challenging applications, consider testing different buffer compositions, adding 1-5% normal serum, or including carrier proteins like BSA to improve specificity. Document your optimization results systematically in a table format, recording signal intensity, background levels, and signal-to-noise ratios for each condition tested to establish a standardized protocol for future experiments .

What considerations should be made when using YLR462W antibodies with different detection systems?

The choice of detection system significantly impacts the performance of YLR462W antibodies across applications. For colorimetric Western blot detection (HRP/AP systems), longer development times may be necessary for low-abundance proteins, but monitor closely to prevent overdevelopment and background. Chemiluminescent detection offers greater sensitivity and dynamic range, making it preferable for quantitative analysis of YLR462W. Fluorescent secondary antibodies provide multiplexing capabilities for co-localization studies but require appropriate controls for autofluorescence, particularly important in yeast cells which can exhibit significant background. If signal amplification is necessary, consider biotin-streptavidin systems or tyramide signal amplification, though these require additional blocking steps to prevent non-specific binding. For immunofluorescence microscopy, select fluorophores compatible with your microscope capabilities and other fluorescent markers in your experiment. When transitioning between detection systems, antibody dilutions will likely need to be re-optimized, as detection sensitivity varies significantly between methods .

What can genomic context analysis tell us about YLR462W function?

Genomic context analysis provides valuable insights into potential YLR462W functions through examination of its chromosomal location, nearby genes, and evolutionary conservation. Drawing parallels from studies of arsenic resistance genes in yeast, the genomic positioning of genes can significantly impact their expression and function . If YLR462W is located in subtelomeric regions like some ARR genes, it may be subject to positional silencing effects that influence its expression patterns. Analyzing synteny (the conservation of gene order) across related yeast species can provide evolutionary context for YLR462W function. Additionally, examining co-expressed genes through transcriptomic data analysis may reveal functional relationships and regulatory networks. The presence of shared regulatory elements in promoter regions of co-expressed genes can further suggest functional relationships. For a comprehensive analysis, consider integrating chromatin structure data, as accessibility of the genomic region can influence expression patterns. These approaches have successfully revealed functional insights for other yeast genes, including how duplication and translocation events affect gene function .

What emerging technologies might enhance YLR462W antibody-based research?

Emerging technologies promise to expand the capabilities of YLR462W antibody-based research in several directions. Single-cell proteomics approaches using microfluidic platforms combined with highly sensitive detection methods could reveal cell-to-cell variability in YLR462W expression levels not detectable in population averages. Super-resolution microscopy techniques such as STORM, PALM, or expansion microscopy paired with YLR462W antibodies could provide unprecedented detail on subcellular localization. Proximity labeling methods like BioID or APEX2 fused to YLR462W could map local protein interaction networks with spatial resolution. CRISPR-based technologies for endogenous tagging would allow live-cell imaging when combined with antibody-based validation. Nanobody or aptamer development against YLR462W could provide smaller probes with better tissue penetration and reduced background, similar to the advantages seen with llama-derived nanobodies in other research contexts . Additionally, automated high-content screening platforms could enable large-scale studies of YLR462W function under numerous genetic or environmental perturbations, accelerating discovery of functional relationships .

How can systems biology approaches integrate YLR462W antibody data with other datasets?

Systems biology approaches can transform discrete YLR462W antibody data into comprehensive biological insights through integration with complementary datasets. Multi-omics integration strategies can correlate protein expression data from YLR462W antibody-based experiments with transcriptomics, metabolomics, and phenotypic data to place the protein within functional networks. Network analysis algorithms can identify potential functional relationships by associating YLR462W with proteins showing similar expression patterns or physical interactions across conditions. Machine learning approaches can help predict protein function based on integrated datasets, particularly valuable for less-characterized proteins like YLR462W. For temporal studies, mathematical modeling can incorporate antibody-derived protein dynamics data to simulate system behavior under various conditions. Public repository data integration allows researchers to contextualizing their YLR462W findings within the broader yeast biology landscape. These approaches have proven valuable in understanding complex gene-function relationships in yeast, as demonstrated in studies of the ARR gene cluster where integration of genomic, transcriptomic, and phenotypic data revealed mechanisms of arsenic resistance .

What are the best practices for reporting YLR462W antibody-based research results?

When reporting research findings using YLR462W antibodies, adhere to rigorous documentation standards to ensure reproducibility and transparency. Always include complete antibody information: catalog number (e.g., CSB-PA519278XA01SVG), lot number, manufacturer, and host species . Detail validation procedures undertaken to confirm antibody specificity, including negative controls and competition assays. Provide comprehensive methodology including exact dilutions, incubation times and temperatures, buffer compositions, and detection methods. Present original, unmodified Western blot images showing molecular weight markers and all visible bands, not just the band of interest. For quantitative analyses, describe normalization methods, technical replicates, and statistical approaches in detail. Include supplementary data showing antibody validation and optimization experiments. Address potential limitations of the antibody's performance and how these were mitigated in your experimental design. Adhering to these reporting standards not only improves the quality and reproducibility of published research but also provides valuable methodological insights for other researchers working with similar systems .

What future research directions should be considered for YLR462W function?

Future research on YLR462W function should explore several promising directions based on current knowledge and technological capabilities. Comparative analysis across different yeast strains (S288c, JAY291, YJM789) may reveal strain-specific functions and regulation mechanisms, similar to those observed with arsenic resistance genes . CRISPR-based approaches for precise genome editing could facilitate comprehensive functional studies through systematic mutation of YLR462W domains. Exploration of environmental stressors and their impact on YLR462W expression could reveal conditional functions not evident under standard laboratory conditions. Protein-protein interaction mapping through techniques like BioID or IP-MS would provide insights into the functional networks in which YLR462W participates. Structural studies of the YLR462W protein could inform mechanism-based hypotheses about its function. Investigation of potential paralogs resulting from duplication events might reveal functional specialization, as observed with other yeast gene families . Finally, translational studies examining homologs in other organisms could extend findings to broader biological contexts. These multifaceted approaches would collectively build a comprehensive understanding of YLR462W function in yeast biology .

How can researchers contribute to improving YLR462W antibody resources?

Researchers can significantly enhance the scientific community's YLR462W antibody resources through several collaborative approaches. Contributing validated protocols to repositories like Protocols.io or the Antibody Registry helps standardize methodologies and reduces redundant optimization efforts. Performing and publishing comprehensive characterization data for commercial antibodies, including specificity tests across multiple yeast strains and applications, provides valuable validation information often not included in manufacturer documentation. Developing and sharing genetic resources such as YLR462W knockout strains or epitope-tagged constructs enhances validation capabilities for the broader community. Establishing collaborations for round-robin testing of antibodies across different laboratories helps identify variables affecting performance and reproducibility. Contributing to community databases by uploading images of blots, microscopy, and other raw data helps establish expected results and variation. Finally, developing standards for antibody validation specific to yeast research would help address the unique challenges of this model system, similar to the standards developed for other research areas .